Spanish National Cancer Research Center-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Spanish National Cancer Research Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013467
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Spanish National Cancer Research Center (CNIO) is a medical research center that offers cancer research programs. The center is an integral cancer research institute which integrates basic and translational cancer research. It conducts various scientific programs which include molecular oncology program, structural biology and biocomputing program, human cancer genetics program, experimental therapeutics program, biotechnology program and clinical research programs. CNIO also offers transfer of technology developed at the institute to innovative companies. The center also offers several training programs and courses for medical residents and master degree holders in other biomedical areas. It also offers practical laboratory courses for undergraduate students and future technicians. CNIO is headquartered in Madrid, Spain.

Spanish National Cancer Research Center – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Pharma Mar Enters into Agreement with Spanish National Cancer Research Centre 10
Licensing Agreements 11
Merck Enters Into Licensing Agreement With Spanish National Cancer Research Centre 11
Inflection Biosciences Enters Into Licensing Agreement With Spanish National Cancer Research Centre For Kinase Inhibitors 12
Spanish National Cancer Research Center – Key Competitors 13
Spanish National Cancer Research Center – Key Employees 14
Spanish National Cancer Research Center – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Government and Public Interest 17
Jul 07, 2016: Various miRNAs predict the effect of anti-angiogenic agents on renal cancer 17
May 25, 2016: International, Multi-Institutional, Women-Led Research Team Receives $900,000 Research Grant from L’Oréal Paris USA and Melanoma Research Alliance to Study Metastatic Melanoma 18
Product News 20
Feb 11, 2016: The CNIO finds a potential therapy for the most aggressive type of lung cancer in preclinical models 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Key Facts 2
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Spanish National Cancer Research Center, Deals By Therapy Area, 2011 to YTD 2017 8
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Pharma Mar Enters into Agreement with Spanish National Cancer Research Centre 10
Merck Enters Into Licensing Agreement With Spanish National Cancer Research Centre 11
Inflection Biosciences Enters Into Licensing Agreement With Spanish National Cancer Research Centre For Kinase Inhibitors 12
Spanish National Cancer Research Center, Key Competitors 13
Spanish National Cancer Research Center, Key Employees 14

★海外企業調査レポート[Spanish National Cancer Research Center-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • KBI Biopharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary KBI Biopharma Inc (KBI) a subsidiary of JSR Corp is a biopharmaceutical contract development and manufacturing organization that develops novel discoveries into life changing biological products. The organization’s service portfolio includes process development and cGMP manufacturing of reco …
  • Mission Pharmacal Company:企業の戦略的SWOT分析
    Mission Pharmacal Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • WideMed Technologies LTD:医療機器:M&Aディール及び事業提携情報
    Summary WideMed Technologies LTD (WideMed) is a medical device company that develops and manufactures information systems for monitoring, diagnosis and analysis of sleep disorders. The company’s products include Morpheus Modules, Morpheus Hx and Morpheus Ox. Its Morpheus modules are automatic scorin …
  • Denali Therapeutics Inc:企業のM&A・事業提携・投資動向
    Denali Therapeutics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Denali Therapeutics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Woolworths Holdings Limited:戦略・SWOT・企業財務分析
    Woolworths Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Woolworths Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Atlantia SpA (ATL):企業の財務・戦略的SWOT分析
    Atlantia SpA (ATL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Mindray Medical International Limited:企業の戦略・SWOT・財務分析
    Mindray Medical International Limited - Strategy, SWOT and Corporate Finance Report Summary Mindray Medical International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Real Matters Inc (REAL):企業の財務・戦略的SWOT分析
    Real Matters Inc (REAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • OSANG Healthcare Co Ltd (036220):製品パイプライン分析
    Summary OSANG Healthcare Co Ltd (OSANG), formerly Infopia Co Ltd is a medical device company that designs, develops and distributes diagnostic biosensors for heart disease and cancers and remote diagnosing systems. The company offers diagnostic biosensors for blood glucose, hemoglobin A1c, cholester …
  • InterHealth Nutraceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary InterHealth Nutraceuticals Inc (InterHealth), a subsidiary of Lonza Group Ltd, is a developer, manufacturer and distributor of nutraceutical ingredients. The company offers nutritional ingredients such as Zychrome, Meratrim, LOWAT, Super CitriMax, ChromeMate, L-OptiZinc, Protykin, ZMA, UC-II …
  • VVC Exploration Corp (VVC):企業の財務・戦略的SWOT分析
    Summary VVC Exploration Corp (VVC) is a mining and mineral exploration company. It is involved in acquisition, exploration, and development of gold, copper, silver, and other mineral properties. Its projects portfolio includes Gloria, Cumeral, La Tuna, and Timmins projects. VVC also offers open-pit …
  • Statoil ASA:企業のM&A・事業提携・投資動向
    Statoil ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Statoil ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Concord New Energy Group Ltd (182):企業の財務・戦略的SWOT分析
    Concord New Energy Group Ltd (182) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Alibaba Pictures Group Limited:企業のM&A・事業提携・投資動向
    Alibaba Pictures Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Alibaba Pictures Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Codan Radio Communications:企業の戦略・SWOT・財務情報
    Codan Radio Communications - Strategy, SWOT and Corporate Finance Report Summary Codan Radio Communications - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Otto Bock HealthCare GmbH:企業の戦略的SWOT分析
    Otto Bock HealthCare GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Driver Group Plc (DRV):企業の財務・戦略的SWOT分析
    Driver Group Plc (DRV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Oriflame Holding AG:企業の戦略・SWOT・財務分析
    Oriflame Holding AG - Strategy, SWOT and Corporate Finance Report Summary Oriflame Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • DHX Media Ltd.:企業のM&A・事業提携・投資動向
    DHX Media Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DHX Media Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Bloomberg L.P.:企業のM&A・事業提携・投資動向
    Bloomberg L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bloomberg L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆